ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.
New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...
Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.
National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.
VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.
The R21 or Matrix-M vaccine has been developed by scientists at Oxford University & is the 2nd to receive WHO recommendation, after RTS,S or AS01 (brand name Mosquirix), approved in 2021.
As devastated farmers begin to come to terms with the fallout, 4 lakh hectares of land under paddy cultivation across state is flooded. Punjab is among the biggest contributors to PDS.
New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour.
Speaking...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS